Figure 1.
(a–d) Maps of four indicators of HIV care in North, Central, and South American Countries, NA-ACCORD and CCASAnet, 2010–2012. (a) Median CD4 count at presentation for HIV clinical care, defined as CD4 cell count within six months of entry into care at one of the participating clinical sites, among those who did not have a suppressed viral load or report previous ART use. (b) Percentage retained in HIV clinical care, defined as the percentage of patients with ≥1 encounter from 2010 to 2012 who had ≥2 HIV primary care visits >90 days apart (measured in the last year an individual contributes data from 2010 to 2012). (c) Percentage of HIV-positive patients prescribed antiretroviral therapy, defined as a the percentage with ≥1 HIV clinical encounter who were prescribed ≥3 antiretroviral agents from at least two classes or a triple nucleoside/nucleotide reverse transcriptase inhibitor regimen containing abacavir or tenofovir for ≥6 months in the last year they contributed from 2010 to 2012. (d) Percentage of HIV-positive patients with suppressed plasma HIV viral load, defined as the percentage of patients with ≥1 HIV clinical encounter and ≥1 HIV-1 plasma RNA measurement who had an HIV-1 RNA ≤200 copies/mL at their last measurement contributed in a calendar year from 2010 to 2012.